Stoke Therapeutics Inc buy BTIG Research
Start price
14.10.25
/
50%
€26.60
Target price
14.10.26
€33.70
Performance (%)
2.26%
Price
30.12.25
€27.20
Summary
This prediction is currently active. The BUY prediction by BTIG_Research shows slight gains of 2.26%. This prediction currently runs until 14.10.26. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Stoke Therapeutics Inc | -4.895% | -4.895% |
| iShares Core DAX® | 0.794% | 2.841% |
| iShares Nasdaq 100 | 0.016% | -0.939% |
| iShares Nikkei 225® | 0.309% | -0.648% |
| iShares S&P 500 | 0.181% | -0.442% |
Comments by BTIG_Research for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics (NASDAQ:STOK) had its price target raised by analysts at BTIG Research from $28.00 to $39.00. They now have a "buy" rating on the stock.
Ratings data for STOK provided by MarketBeat
Stopped prediction by BTIG_Research for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€19.00
05.11.25
05.11.25
€33.93
05.11.26
05.11.26
43.16%
30.12.25
30.12.25
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€15.60
18.08.25
18.08.25
€23.93
18.08.26
18.08.26
74.36%
30.12.25
30.12.25